PubMed

Risk of Recall Associated With Modifications to High-risk Medical Devices Approved Through US Food and Drug Administration Supplements.

PMID: 37043202 · 2023-04-03

J, o, n, a, t, h, a, n, , R, , D, u, b, i, n, ;, , J, o, n, a, t, h, a, n, , R, , E, n, r, i, q, u, e, z, ;, , A, n, -, L, i, n, , C, h, e, n, g, ;, , H, u, n, t, e, r, , C, a, m, p, b, e, l, l, ;, , A, k, i, n, , C, i, l

ЖурналJAMA network open

Год2023-04-03

PMID37043202

Аннотация

High-risk medical devices approved by the US Food and Drug Administration (FDA) can undergo modifications to their original premarket approval (PMA) via 1 of 5 types of supplements. Only panel track supplements (approximately 1%) require clinical data for approval. The association between device modifications and risk to patient safety has not previously been analyzed. To determine the association between PMA supplements and the risk of any device recall and high-risk (class 1) recall. In this c

Официальный источник

Открыть в PubMed →

Данные получены из PubMed / NCBI. Полный текст и наиболее актуальную информацию всегда смотрите в официальной записи.